期刊文献+

药品不良反应信号检测中遮蔽效应的影响及消除方法 被引量:4

Masking Effect in the Process of Signal Detection of Adverse Drug Reaction
下载PDF
导出
摘要 常规的药品不良反应信号检测方法基于不相称测定理论,在药品不良反应监测中发挥着重要的作用。然而这些方法在信号检测准确性中存在一些缺陷,无法很好地解决一些现象,如遮蔽效应等。这些现象需要基于新的策略对数据进行分析,本文介绍遮蔽效应对信号检测准确性的影响,以及如何发现和消除遮蔽效应的研究进展。 Routine adverse drug reaction signal detection methods based on disproportionality analysis are playing important role in the process of adverse drug reaction surveillance. However, these methods have their own drawbacks in the accuracy for signal detection and could not solve some problems which include masking effect. These problems should be solved through new analysis strategy. In this article, we present the impact of masking effect on the signal detection and introduce the latest research on the identification and elimination of masking effect.
出处 《中国药物警戒》 2013年第1期33-35,共3页 Chinese Journal of Pharmacovigilance
基金 国家自然科学基金资助项目(No.30872186 No.81072388 No.81202285) 上海市自然科学基金资助项目(12ZR1453700) 上海市优秀学科带头人计划(A类)(No.09XD1405500) 2010年上海市领军人才计划(022) 上海市循证公共卫生重点学科(12GWZX0602)
关键词 遮蔽效应 药品不良反应 信号检测 masking effect adverse drug reaction signal detection
  • 相关文献

参考文献12

  • 1Norén G N,Hopstadius J,Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery[J].Statistical Methods in Medical Research,2011.
  • 2Eugene P.van Puijenbroek,Andrew Bate,Hubert G.M.Leufkens. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions[J].Pharmacoepidemiology and Drug Safety,2002.3-10.
  • 3Norén GN,Sundberg R,Bate A. A statistical methodology for drug-drug interaction surveillance[J].Statistics in Medicine,2008,(16):3057-3070.doi:10.1002/sim.3247.
  • 4Strandell J,Caster O,Bate A. Reporting patterns indicative of adverse drug interactions-a systematic evaluation[J].Drug Safety,2011,(03):253-266.
  • 5Almenoff J,Tonning J M,Gould AL. Perspectives on the use of data mining in pharmaco-vigilance[J].Drug Safety,2005,(11):981-1007.
  • 6Wang H W,Hochberg A M,Pearson R K. An experimental investigation of masking in the US FDA adverse event reporting system database[J].Drug Safety,2010.1117-1133.
  • 7周静雯,苏雅茹.世界卫生组织药物词典及其应用[J].药物流行病学杂志,2011,20(9):478-483. 被引量:4
  • 8Pariente A,Didailler M,Avillach P. A potential competition bias in the detection of safety signals from spontaneous reporting databases[J].Pharmacoepidemiology and Drug Safety,2010.1166-1171.
  • 9Ziad Zeinoun,Harry Seifert,Thomas Verstraeten. Quantitative signal detection for vaccines Effect of stratification,background and masking on GlaxoSmithKline's spontaneous reports database[J].Human Vaccines,2009,(09):599-607.
  • 10Caster O,Norén GN,Madigan D. Large-Scale Regression-Based Pattern Discovery:The Example of Screening the WHO Global Drug Safety Database[J].Statistical analysis and data mining,2010.197-207.

二级参考文献11

  • 1World Health Organization Uppsala Monitoring Committee. WHO Drug Dictionary Sample Getting Started document [ EB/OL]. http ://www. umc-products, com/DynPage, aspx? id = 2844.
  • 2Alghabban A. Dictionary of Pharmacovigilance [ M ]. London : Pharmaceutical Press, 2004.
  • 3Lindquist M. Vigibase, the WHO Global ICSR Database System : Basic Facts [ J ]. Drug Information Journal, 2008, 42:409-419.
  • 4Welcome to the WHO Drug Dictionary ( version 28May2003). The Uppsala Monitoring Centre[EB/OL]. http ://www. pharmadhoc, com/WHO _ Drug _ Dictionary _ Guide. pdf.
  • 5Report from the WHO Collaborating Centre for International Drug Monitoring Activities July 2003 - June 2004 [ EB/ OL]. http : / /www. who-urnc, org/ graphics/6937, pdf.
  • 6Structure and principles . WHO Collaborating Centre for Drug Statistics Methodology [ EB/OL]. http://www. whocc, no/ atc/structure_and__principles/.
  • 7Talbot J, Waller P. Stephens' s Detection of New Adverse Drug Reactions [ M]. 5th ed. West Sussex: John Wiley & Sons Ltd, 2004. 533-557.
  • 8Report from the WHO Collaborating Centre for International Drug Monitoring Activities July 2003 -June 2004 [ EB/OL].http ://www. who-umc, org/graphics/6937, pdf.
  • 9Peppard TE. Using the WHO Drug Dictionary for Reporting Clinical Trials [ C ]. MWSUG 2007 Meeting. 2007. S6.
  • 10Star K, Noren G. N, Nordin K,et al. Suspected adverse drug reactions reported for children worldwide [ J ]. Drug Safety, 2011, 34(5) : 415-428.

共引文献3

同被引文献31

  • 1World Health Orgization. WHO guidelines on safety monito- ring of herbal medicines in pharmacovigilance systems [ EB/ OL ]. http : / / whqlibdoc, who. int/ / publications/2004 / 9241592214_eng. pdf, 2004. 9. 1.
  • 2Dell' Aera M, Gasbarro AR, Padovano M, et al. Unli- censed and off-label use of medicines at a neonatology clinic in Italy[J]. Pharm World Sci, 2007,29(4):361-367.
  • 3Strandell J, Caster O, Bate A, et al. Reporting patterns in- dicative of adverse drug interactions: a systematic evaluation in VigiBase [ J ]. Drug Saf, 2011,34 ( 3 ) :253-266.
  • 4Brown EG. Methods and pitfalls in searching drug safety da- tabases utilising the Medical Dictionary for Regulatory Activ- ities (MedDRA) [ J ]. Drug Saf, 2003,26 (3) : 145-158.
  • 5Almenoff J, Tonning JM, Gould AL, et al. Perspectives onthe use of data mining in pharmacovigilance [ J ]. Drug Safe- ty, 2005,28(11) :981-1007.
  • 6Pearson RK, Hauben M, Goldsmith DI, et al. Influence of the MedDRA hierarchy on pharmacovigilance data mining re- sults[J]. Int J Med Inform, 2009,78(12) :e97-e103.
  • 7Bate AERLM. The authorsi'eply[Z]. 2003. 26, 364-366.
  • 8王超.倾向性评分法及在药品不良反应信亏检测中的应用[D].上海:第二军医大学硕士学位论文,2012.
  • 9Crystal S, Akincigil A, Bilder S, et al. Studying prescrip- tion drug use and outcomes with medicaid claims data: strengths, limitations, and strategies[ J ]. Med Care, 2007, 45(10 Supl 2) :$58-$65.
  • 10Juhlin K, Ye X, Star K, et al. Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple un- masking strategy[ J]. Pharmacoepidemiol Drug Saf, 2013, 22(10) : 1119-1129.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部